MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0356|78|1|49-55

ISSN： 0025-7931

Source： Respiration, Vol.78, Iss.1, 2008-09, pp. : 49-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDR1 Single Nucleotide Polymorphisms Predict Response to Vinorelbine-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer

By  

Respiration, Vol. 75, Iss. 4, 2007-09 ,pp. : 380-385

Karger

Access to resources Recommend Favorite

Lack of Association between MDR1 G2677T/A Polymorphism and Leukemia Risk: An Updated Meta-Analysis

By  

Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-06 ,pp. : 383-384

Karger

Access to resources Recommend Favorite

A 53-Year-Old Patient with Unilateral Pulmonary Infiltrates following a Single Dose of Mitomycin, Vindesine and Cisplatin Chemotherapy for Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 66, Iss. 6, 1999-11 ,pp. : 562-572

Karger

Access to resources Recommend Favorite

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer (Stage IIIb or IV) with a Higher T Stage (> T2)

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 173-179

Karger

Access to resources Recommend Favorite